Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

about

Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis

P2860

Q34577136-9FAA3E93-EA21-4485-ACA3-F606E22AD19B

P2860

Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

Item

http://www.wikidata.org/entity/Q58004676

description

scientific article published on 01 January 1999

@en

наукова стаття, опублікована в січні 1999

@uk

name

Recombinant interferon alpha ( ...... h HCV chronic active hepatitis

@en

type

Item

label

Recombinant interferon alpha ( ...... h HCV chronic active hepatitis

@en

prefLabel

Recombinant interferon alpha ( ...... h HCV chronic active hepatitis

@en

P1476

Recombinant interferon alpha ( ...... h HCV chronic active hepatitis

@en

P2093

C Schianchi

http://www.w3.org/2001/XMLSchema#string

E Roti

http://www.w3.org/2001/XMLSchema#string

F Fiaccadori

http://www.w3.org/2001/XMLSchema#string

M A Valli

http://www.w3.org/2001/XMLSchema#string

M G Magotti

http://www.w3.org/2001/XMLSchema#string

M Pedrazzoni

http://www.w3.org/2001/XMLSchema#string

M Salvi

http://www.w3.org/2001/XMLSchema#string

R Minelli

http://www.w3.org/2001/XMLSchema#string

P2860

Autoimmune thyroiditis: predisposition and pathogenesis.

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.

Autoimmune thyroid disease: further developments in our understanding.

Impaired intrathyroidal iodine organification and iodine-induced hypothyroidism in euthyroid women with a previous episode of postpartum thyroiditis.

Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration.

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.

Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter.

Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease.

Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice.

Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment

P304

95-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2265.1999.00616.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lewis E Braverman

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10341861

http://www.w3.org/2001/XMLSchema#string

Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

about

P2860

P2860

Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698